01 Jan 2025
// FDA
18 Dec 2024
// PR NEWSWIRE
26 Jun 2024
// FDA
Latest Content by PharmaCompass
About
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
01 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2025-88420.pdf
18 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breckenridge-announces-final-fda-approval-for-methadone-hydrochloride-multi-dose-injection-302334969.html
26 Jun 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf
15 May 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2024-59166.pdf
24 Jan 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208220
21 Dec 2023
// INDIAN PHARMA POST
https://www.indianpharmapost.com/news/natco-pharma-and-breckenridge-dismissed-from-antitrust-lawsuit-15044
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 125MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : ACETAZOLAMIDE
Dosage Strength : 250MG
Approval Date : 2020-04-30
Application Number : 207503
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 10MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 25MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 50MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 75MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 100MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : TABLET; ORAL
Proprietary Name : AMITRIPTYLINE HYDROCHLOR...
Dosage Strength : 150MG
Approval Date : 2022-06-06
Application Number : 216243
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 2.5MG
Approval Date : 2021-07-26
Application Number : 209845
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : APIXABAN
Dosage Strength : 5MG
Approval Date : 2021-07-26
Application Number : 209845
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Inspections and registrations
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?